HealthEquity (FRA:2HE) Mohanram G-Score: 6 (As of Apr. 2026) — 20% Above Median


FRA:2HE HealthEquity Inc FRA:2HE
92 GF Score
Price €76.50
GF Value €87.33
! 1 Warning Sign
View Full Analysis

What is HealthEquity Mohanram G-Score?

HealthEquity FRA:2HE -0.65% 92 Mohanram G-Score is 6 as of Apr. 2026, which is 20% above its 10-year median of 5.00. GuruFocus rates FRA:2HE with a GF Score™ of 92/100 and a GF Value™ of €87.33. The stock has 1 warning sign investors should review.

Mohanram G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. Companies have higher G-score tends to generate higher return. According to his study, the best growth stocks that have a G-Score greater than 6 tend to beat the market, while those with a G-Score lower than 1 tend to have negative absolute returns.

Thus, the zones of discrimination were as such:

Good or high score = 6, 7, 8
Bad or low score = 0, 1

HealthEquity has an G-score of 6. It is a good or high score, which tends to beat the market.

The historical rank and industry rank for HealthEquity's Mohanram G-Score or its related term are showing as below:

FRA:2HE' s Mohanram G-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 6
Current: 6

During the past 13 years, the highest Piotroski G-score of HealthEquity was 6. The lowest was 4. And the median was 5.

HealthEquity  (FRA:2HE) Mohanram G-Score Explanation

Partha Mohanram is the John H. Watson Chair in Value Investing at Rotman and the Acting Vice-Dean of Research Strategy and Resources.

In 2000, he wrote a research paper called "Separating Winners from Losers Among Low Book-to-Market Stocks Using Financial Statement Analysis".

This paper tests whether a strategy based on financial statement analysis of low book-to-market (growth) stocks is successful in differentiating between winners and losers in terms of future stock performance. Based on the research, a strategy based on buying high G-score (6, 7 or 8) firms and shorting low G-score (0 or 1) firms consistently earns significant excess returns. Further, the results do not support a risk based explanation for the book-to-market effect as the strategy returns positive returns in all years, and firms that ex-ante appear less risky have better future returns.

To conclude, one can use a modified fundamental analysis strategy (G-score) to identify mispricing and earn substantial abnormal returns.


HealthEquity Mohanram G-Score Related Terms


HealthEquity Mohanram G-Score Historical Data

* Premium members only.

The historical data trend for HealthEquity's Mohanram G-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity Mohanram G-Score Chart

HealthEquity Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Mohanram G-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 5.00 5.00 5.00 6.00

HealthEquity Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Mohanram G-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 6.00 6.00 6.00 6.00

FRA:2HE vs HNGE, TEM, TXG: Mohanram G-Score Comparison

For the Health Information Services subindustry, HealthEquity's Mohanram G-Score, along with its competitors' market caps and Mohanram G-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity Mohanram G-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Mohanram G-Score distribution charts can be found below:

* The bar in red indicates where HealthEquity's Mohanram G-Score falls into.


FRA:2HE
92GF Score
HealthEquity Inc FRA:2HE
Mohanram G-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthEquity Mohanram G-Score Calculation

The calculation of the Mohanram G-score consists of eight criteria. Assign one point for each criterion met, then add up all the points to get the G-Score.

Profitability

Question 1. Return on Assets (ROA)

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. It measures how well a company uses its asset to generate earnings.

Score 1 if ROA > ROA Industry Median, 0 otherwise.

Question 2. Cash ROA

Cash ROA equals to Cash Flow from Operations divided by average Total Assets. It measures how well a company uses its asset to generate cash.

Score 1 if Cash ROA > Cash ROA Industry Median, 0 otherwise.

Question 3. CFO and Net Income

Score 1 if CFO > Net Income, 0 otherwise.

Earnings Predictability

Question 4. Earnings Variability

Earnings Variability is measured as the variance of a firm's ROA in the past five years.

Score 1 if Earnings Variability < Earnings Variability Industry Median, 0 otherwise.

Question 5. Sales Growth Variability

Sales Growth Variability is measured as the 5-year variance in sales growth.

Score 1 if Sales Growth Variability < Sales Growth Variability Industry Median, 0 otherwise.

Accounting Conservatism

Question 6. Research & Development Intensity

Research & Development Intensity is calcualted by Research & Development divided by the beginning Total Assets.

Score 1 if Research & Development Intensity > Research & Development Intensity Industry Median, 0 otherwise.

Question 7. CAPEX Intensity

CAPEX Intensity is calcualted by Capital Expenditure divided by the beginning Total Assets.

Score 1 if CAPEX Intensity > CAPEX Intensity Industry Median, 0 otherwise.

Question 8. Advertising Expenditure Intensity

Advertising Expenditure Intensity is calcualted by Advertising Expenditure divided by the beginning Total Assets. Note that Advertising Expenditure is not reported as a seperate line item for many companies, thus Selling, General, & Admin. Expense is used in this calculation.

Score 1 if Advertising Expenditure Intensity > Advertising Expenditure Intensity Industry Median, 0 otherwise.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note that all the Industry Median used for comparison in his original research, are substituted with Sector Median due to the limitation of data within certain countries.

Good or high score = 6, 7, 8
Bad or low score = 0, 1

HealthEquity has an G-score of 6. It is a good or high score, which tends to beat the market.

Frequently Asked Questions Learn more about Mohanram G-Score →
What does a Mohanram G-Score of 6 mean?
HealthEquity (FRA:2HE) has a Mohanram G-Score of 6 as of Apr. 2026. G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. View historical data on HealthEquity and its competitors. This is 20% above median its historical median of 5.00. Over the past decade, HealthEquity's Mohanram G-Score has ranged from 4.00 to 6.00.
Is HealthEquity's Mohanram G-Score too high?
HealthEquity's current Mohanram G-Score of 6 is 20% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 6.00. Overall, HealthEquity has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Mohanram G-Score compare to HNGE and TEM?
HealthEquity's Mohanram G-Score of 6 can be compared against companies in the Healthcare Providers & Services industry. Historically, HealthEquity's own Mohanram G-Score has ranged from 4.00 to 6.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Mohanram G-Score for a Healthcare Providers & Services company?
A good Mohanram G-Score depends on the Healthcare Providers & Services industry context. However, Mohanram G-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Mohanram G-Score mean?
A high Mohanram G-Score can signal that a stock is expensive relative to its fundamentals. G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. View historical data on HealthEquity and its competitors. HealthEquity's current Mohanram G-Score is 6, which is 20% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Mohanram G-Score of 6. The stock's GF Value™ is €87.33, compared to a current price of €76.50 — trading 12.4% below its estimated fair value. The current Mohanram G-Score is 6, which is 20% above median its 10-year median of 5.00. HealthEquity's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Mohanram G-Score calculated?
Mohanram G-Score is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Mohanram G-Score is 6 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (FRA:2HE) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of €76.50 is trading 12.4% below its estimated GF Value™ of €87.33.

Key valuation signals for FRA:2HE:

  • Mohanram G-Score: 6 (20% above median its 10-year median of 5.00)
  • GF Value™: €87.33 vs. price of €76.50 (12.4% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthEquity Business Description

Other Exchanges HQY:USA
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
92GF Score

Get the complete analysis for FRA:2HE

Mohanram G-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€76.50
Price
€87.33
GF Value